BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Drug Development

  Nektar Therapeutics (CA) Presents Data On Target-Specific Biomarkers From Circulating Tumor Cell Sub-Study Of Phase 3 BEACON Study Of Etirinotecan Pegol (NKTR-102) In Patients With Advanced Breast Cancer

  December 12, 2014

   · 

  10 min read
• Drug Development

  Synta Pharmaceuticals Announces Presentation Of Results From An Investigator-Sponsored Phase 1 Trial Of Ganetespib In HER2+ Metastatic Breast Cancer At The 2014 San Antonio Breast Cancer Symposium

  December 12, 2014

   · 

  5 min read
• Biotech Beach

  Halozyme Therapeutics, Inc. Announces Presentations Of Preclinical Data At The San Antonio Breast Cancer Symposium Annual Meeting

  December 12, 2014

   · 

  4 min read
• FDA

  Sanofi Pasteur Announces FDA Approval Of Fluzone Intradermal Quadrivalent (Influenza Vaccine) For Adults

  December 12, 2014

   · 

  10 min read
• Genetown

  Human Design Medical, LLC Release: Introducing The Z1 Auto And Nitelog - A New Chapter In Sleep Therapy

  December 12, 2014

   · 

  2 min read
• Genetown

  New Data Presented At Nans 2014 Demonstrate Long-Term, Low Back Pain Relief With Boston Scientific Corporation Precision Spectra Spinal Cord Stimulator System

  December 12, 2014

   · 

  7 min read
• Biotech Bay

  Alexza Pharmaceuticals, Inc. Release: Diario Medico Names ADASUVE In Its “Best Ideas Of 2014"

  December 12, 2014

   · 

  6 min read
• Lone Star Bio

  MD Anderson Cancer Center Officials React To FDA Approval Of Gardasil 9 For The Prevention Of Certain Cancers

  December 12, 2014

   · 

  2 min read
• GRCI 2014 Update: CeloNova BioSciences’ COBRA Pzf™ Coronary Stent Achieves A Low 3% TLR With Short DAPT

  December 12, 2014

   · 

  2 min read
• Business

  Champions Oncology, Inc. Reports Results For The Second Quarter Ended October 31, 2014

  December 12, 2014

   · 

  3 min read